GlobeNewswire Inc.··Anaveon AgBiotech Veteran Ramanayake Takes Helm at Anaveon as Immune Reprogramming Firm Pursues Clinical Trials
Anaveon appoints veteran biotech executive Thaminda Ramanayake as CEO to guide lead candidate ANV200 through clinical development for autoimmune and inflammatory diseases.
PFENVSBNTXclinical developmentautoimmune diseases